EUVIMEDEUVIMED entdecken
Crossref

Full Active Nanoplatform Restores ROS Homeostasis for Synergistic Therapy of Fatty Liver Disease via Dual Endogenous–Exogenous Pathways

Ziyi Lin, Peng Xu, Yuehai Xu, Yixin Zheng, Huimin Li, Zixin Chen, Zhe Wang, Shaochen Song, Yuhao Liu, Zhao Yang, Ju Cui, Heyun Shen iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c15203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Ziyi Lin und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organic-Inorganic Composites, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing Universit…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Fatty Liver, Antioxidants, Nanoparticles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesFatty LiverAntioxidantsNanoparticlesNon-alcoholic Fatty Liver DiseaseAnimalsMiceHomeostasisHumansPolymersQuercetinMaleMice, Inbred C57BLIndoles

Stichwörter der Autor:innen

APIMASHPDAROS homeostasismitochondrial uncoupler

Substanzen

Reactive Oxygen SpeciesAntioxidantsPolymersQuercetinpolydopamineIndoles

Autor:innen und Institutionen

  • State Key Laboratory of Organic-Inorganic Composites, Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
  • The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital/National Center of Gerontology of National Health Commission, Beij…

ORCID-Profile: Heyun Shen

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China
  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Lin, Z., Xu, P., Xu, Y., Zheng, Y., Li, H., Chen, Z., Wang, Z., Song, S., Liu, Y., Yang, Z., Cui, J., & Shen, H. (2025). Full Active Nanoplatform Restores ROS Homeostasis for Synergistic Therapy of Fatty Liver Disease via Dual Endogenous–Exogenous Pathways. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c15203

Vancouver

Lin Z, Xu P, Xu Y, Zheng Y, Li H, Chen Z, et al. Full Active Nanoplatform Restores ROS Homeostasis for Synergistic Therapy of Fatty Liver Disease via Dual Endogenous–Exogenous Pathways. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c15203

BibTeX
@article{Lin2025,
  author = {Lin, Ziyi and Xu, Peng and Xu, Yuehai and Zheng, Yixin and Li, Huimin and Chen, Zixin and Wang, Zhe and Song, Shaochen and Liu, Yuhao and Yang, Zhao and Cui, Ju and Shen, Heyun},
  title = {Full Active Nanoplatform Restores ROS Homeostasis for Synergistic Therapy of Fatty Liver Disease via Dual Endogenous–Exogenous Pathways},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c15203}
}
Kostenlos starten →